260 related articles for article (PubMed ID: 33214972)
21. Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia.
Chalermchai T; Tantiphlachiva K; Suwanrusme H; Voravud N; Sriuranpong V
Asia Pac J Clin Oncol; 2010 Sep; 6(3):155-60. PubMed ID: 20887495
[TBL] [Abstract][Full Text] [Related]
22. Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin.
Gordinier ME; Dizon DS; Fleming EL; Weitzen S; Schwartz J; Parker LP; Granai CO
Gynecol Oncol; 2006 Oct; 103(1):72-4. PubMed ID: 16494932
[TBL] [Abstract][Full Text] [Related]
23. Clinical risk factors of PEGylated liposomal doxorubicin induced palmar plantar erythrodysesthesia in recurrent ovarian cancer patients.
Ko EM; Lippmann Q; Caron WP; Zamboni W; Gehrig PA
Gynecol Oncol; 2013 Dec; 131(3):683-8. PubMed ID: 24096112
[TBL] [Abstract][Full Text] [Related]
24. Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.
Kara IO; Sahin B; Erkisi M
Breast; 2006 Jun; 15(3):414-24. PubMed ID: 16188440
[TBL] [Abstract][Full Text] [Related]
25. Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study.
Tan AR; Johannes H; Rastogi P; Jacobs SA; Robidoux A; Flynn PJ; Thirlwell MP; Fehrenbacher L; Stella PJ; Goel R; Julian TB; Provencher L; Bury MJ; Bhatt K; Geyer CE; Swain SM; Mamounas EP; Wolmark N
Breast Cancer Res Treat; 2015 Jan; 149(1):163-9. PubMed ID: 25542269
[TBL] [Abstract][Full Text] [Related]
26. Case series of docetaxel-induced dorsal hand-foot syndrome.
Patel J; Ringley JT; Moore DC
Ther Adv Drug Saf; 2018 Aug; 9(8):495-498. PubMed ID: 30364883
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors.
Mavroudis D; Kouroussis Ch; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Samonis G; Georgoulias V
Oncology; 2002; 62(3):216-22. PubMed ID: 12065868
[TBL] [Abstract][Full Text] [Related]
28. A case of palmar-plantar erythrodysesthesia in a lung cancer patient receiving atezolizumab maintenance.
Teymouri F; Dasanu CA
J Oncol Pharm Pract; 2024 May; ():10781552241258175. PubMed ID: 38813782
[TBL] [Abstract][Full Text] [Related]
29. Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial.
Schneeweiss A; Möbus V; Tesch H; Hanusch C; Denkert C; Lübbe K; Huober J; Klare P; Kümmel S; Untch M; Kast K; Jackisch C; Thomalla J; Ingold-Heppner B; Blohmer JU; Rezai M; Frank M; Engels K; Rhiem K; Fasching PA; Nekljudova V; von Minckwitz G; Loibl S
Eur J Cancer; 2019 Jan; 106():181-192. PubMed ID: 30528802
[TBL] [Abstract][Full Text] [Related]
30. Docetaxel-induced Hand and Foot Syndrome in a Patient with Metastatic Breast Carcinoma.
Gurumurthi R; Nimmagadda RB; Mohan S
Indian J Dermatol; 2013 Sep; 58(5):380-2. PubMed ID: 24082184
[TBL] [Abstract][Full Text] [Related]
31. Grade 3 liposomal-doxorubicin-induced skin toxicity in a patient following complete resolution of moderately severe sunburn.
Markman M; Kulp B; Peterson G
Gynecol Oncol; 2004 Aug; 94(2):578-80. PubMed ID: 15297208
[TBL] [Abstract][Full Text] [Related]
32. Trastuzumab-induced hepatotoxicity.
Srinivasan S; Parsa V; Liu CY; Fontana JA
Ann Pharmacother; 2008 Oct; 42(10):1497-501. PubMed ID: 18780811
[TBL] [Abstract][Full Text] [Related]
33. Prevention of palmoplantar erythrodysesthesia in patients treated with pegylated liposomal doxorubicin (Caelyx®).
Jung S; Sehouli J; Chekerov R; Kluschke F; Patzelt A; Fuss H; Knorr F; Lademann J
Support Care Cancer; 2017 Nov; 25(11):3545-3549. PubMed ID: 28653108
[TBL] [Abstract][Full Text] [Related]
34. Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer.
Eich D; Scharffetter-Kochanek K; Eich HT; Tantcheva-Poor I; Krieg T
Am J Clin Oncol; 2002 Dec; 25(6):599-602. PubMed ID: 12478008
[TBL] [Abstract][Full Text] [Related]
35. Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Janinis J; Stathopoulos GP; Nikolaidis P; Kalofonos HP; Kalogera-Fountzila A; Samantas E; Aravantinos G; Anagnostopoulos A; Tolis C; Makatsoris T; Rigatos SK; Bafaloukos D; Dimopoulos MA; Daniilidis J; Fountzilas G
Anticancer Drugs; 2004 Jun; 15(5):479-87. PubMed ID: 15166622
[TBL] [Abstract][Full Text] [Related]
36. Nanoparticle albumin-bound paclitaxel in a patient with locally advanced breast cancer and taxane-induced skin toxicity: a case report.
Cirauqui BC; García VQ; Rubio CL; Miguel MI; Riera LC; Aranda NP; Martín SV; Martínez AM; Caruncho CR; Vila MM
J Med Case Rep; 2014 Jan; 8():6. PubMed ID: 24386978
[TBL] [Abstract][Full Text] [Related]
37. Prevention strategies in palmar-plantar erythrodysesthesia onset: the role of regional cooling.
Mangili G; Petrone M; Gentile C; De Marzi P; Viganò R; Rabaiotti E
Gynecol Oncol; 2008 Feb; 108(2):332-5. PubMed ID: 18083217
[TBL] [Abstract][Full Text] [Related]
38. Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy.
Fontenot AL; Furr WJ; Husan A; Khan MW
Cureus; 2021 Nov; 13(11):e20060. PubMed ID: 34993032
[TBL] [Abstract][Full Text] [Related]
39. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Loibl S; O'Shaughnessy J; Untch M; Sikov WM; Rugo HS; McKee MD; Huober J; Golshan M; von Minckwitz G; Maag D; Sullivan D; Wolmark N; McIntyre K; Ponce Lorenzo JJ; Metzger Filho O; Rastogi P; Symmans WF; Liu X; Geyer CE
Lancet Oncol; 2018 Apr; 19(4):497-509. PubMed ID: 29501363
[TBL] [Abstract][Full Text] [Related]
40. Palmar-plantar erythrodysesthesia associated with high-dose methotrexate: Case report.
Chauhan P; Gupta A; Kumar S; Bishnu A; Nityanand S
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1270. PubMed ID: 32767666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
